Search

You searched for "SLT"

2594 results found

The meaning of life

1 December 2021 | | EYE - Vitreo-Retinal, EYE - General
Supercomputer: “The answer to the great question of Life, the Universe and Everything is…”Programmer: “Yes…?”Supercomputer: “42. It was a tough assignment”.Programmer: “42? Is that all you have got to show for seven and a half million years work?” In this...

It’s Friday, I’m In Love: Pete’s Hidden Curriculum Part 3

3 February 2023 | | EYE - General
“When you’re in love, it’s the most glorious two-and-a-half days of your life.” - Richard Lewis [1]. The good news is that we are over the hump now and past the most depressing day of the year, which is known...

A window to 2024 and beyond?

3 April 2024 | | EYE - Cornea
The connection between the eye and systemic diseases has been acknowledged for millenia. Historical records suggest that ancient civilisations had some understanding of the eye’s significance beyond its primary function in vision. For instance, in ancient Egypt, the ‘Eye of...

The symbolism of eyes in Halloween traditions and popular culture

31 October 2025 | | EYE - General
Halloween is a festival steeped in symbolism. Pumpkins, skeletons, ghosts and witches dominate the seasonal iconography, each representing broader cultural anxieties about death, darkness and the supernatural. Among these motifs, the eye, often depicted as glowing, disembodied or grotesquely exaggerated,...

In conversation with Fares Antaki: The retinal age gap in schizophrenia

3 April 2026 | | EYE - Vitreo-Retinal
Fares Antaki. Nima Ghadiri (NG): The ‘retinal age gap’ (RAG) is a relatively new concept. Based on your study [1], how confident are you in proposing this as a non-invasive, accessible biomarker for accelerated biological ageing in patients with neuropsychiatric...

Glaucoma UK names 2026 Excellence in Glaucoma Care Award winners

28 April 2026 | awards, charity
Glaucoma UK is delighted to announce the winners of its 2026 Excellence in Glaucoma Care Awards, recognising outstanding individuals and teams who are transforming glaucoma care for patients across the UK. Individual Excellence in Glaucoma Care Award (joint winners) Mr...

My Top Five: Innovative approaches to dry AMD

2 February 2024 | | EYE - General
Age-related macular degeneration (AMD) is one of the leading causes of irreversible blindness in the developing world with its prevalence rising alongside age. In societies characterised by ageing populations, it is imperative we explore more effective treatment to alleviate the...

The eye surgeon and eye physician together: the joint ophthalmic clinic

3 February 2023 | | EYE - General
Since the early 19th century, physicians and surgeons have been working together in eye clinics and hospitals to bring about the best outcome for the patients. From the early Babylonian age, important advances in ophthalmic knowledge arose in a stuttered...

Paediatric choroidal neovascular membrane secondary to optic disc drusen

5 August 2026 | | EYE - Paediatrics, EYE - Vitreo-Retinal
Choroidal neovascular membrane (CNVM) is a rare cause of visual impairment in paediatric populations and predominantly affects individuals aged over 50. CNVM is defined as the pathologic growth of new abnormal blood vessels which extend from the choroid and break...

Scholarships, awards and prizes

5 December 2025 | | EYE - General
Perhaps one of the less well-known benefits of being a member of the Royal College of Ophthalmologists (RCOphth) is access to the range of scholarships, awards and prizes that we offer. Many of you will be aware of the annual...

High-stakes scenarios in retinal vein occlusion: A survey of medico-legal implications

2 October 2025 | | EYE - Vitreo-Retinal, EYE - Glaucoma
Central retinal vein occlusion (CRVO) is the second most common retinal vascular disease after diabetic retinopathy, and its clinical complexity often intersects with medico-legal scrutiny [1]. Missteps in timely diagnosis, inadequate follow-up or poor documentation can lead to patient harm...

2019 ICO-Allergan Research Fellowship awarded

4 July 2019
Dr Matias Iglicki, from the University of Buenos Aires in Argentina, has been selected as the second recipient of the International Council of Ophthalmology (ICO)-Allergan Fellowship Award, by a panel of leading experts.